Join us for the inaugural edition of the Global Precision Medicine Summit
Precision medicine is a rapidly growing approach to disease prevention and treatment. The MEA precision medicine market is rapidly evolving, with rising use of gene therapy across the region, as well as the use of big data analytics and advanced technologies in precision medicine to improve the prevention and treatment of chronic illnesses, uncommon diseases, and even cancer.
This new frontier of combining digital data and gene therapy is paving the door for new healthcare R&D, with a MEA market share of USD 4.4 billion estimated for 2022.
The goal of GPMS is to investigate the clinical, scientific, and logistic consequences of personalized therapeutics made available by the Middle East’s genomic revolution. With the use of artificial intelligence, the United Arab Emirates hopes to be the first country in the world to have the genetic sequencing of its entire population.
GPMS 2022: the new frontier of healthcare
- #Pharmacists
- #Chief Pharmacists
- #Healthcare Professionals
- #C-Levels
- #Directors
- #Purchasing and facilities
- #Plant Managers
- #Managers of Production and Regulatory Affairs
- #Quality control
- #Information Technology
- Marketing and Business Development Executives of:
- #Pharmacies: Chains, online, independent, Hospital
- #Medicine and OTC product distributors and wholesalers
- #Government/ Health Authorities
- #Drugs and Generics Manufacturers
- #Nutraceuticals Manufacturers
- #Contract Manufacturers
- #Pharma Machinery Distributors
- #Packaging products and Solutions Distributors
- #APIs and raw materials Lab Equipment Distributors